Guardian Asset Advisors LLC Sells 406 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Guardian Asset Advisors LLC decreased its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 9.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,114 shares of the medical instruments supplier’s stock after selling 406 shares during the quarter. Guardian Asset Advisors LLC’s holdings in Merit Medical Systems were worth $398,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Farther Finance Advisors LLC boosted its position in Merit Medical Systems by 32.7% during the third quarter. Farther Finance Advisors LLC now owns 1,056 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares during the last quarter. Harvest Fund Management Co. Ltd bought a new stake in shares of Merit Medical Systems during the 3rd quarter worth approximately $120,000. GAMMA Investing LLC boosted its holdings in shares of Merit Medical Systems by 14.7% in the 4th quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier’s stock valued at $144,000 after buying an additional 191 shares during the last quarter. TD Private Client Wealth LLC raised its position in Merit Medical Systems by 13.9% during the third quarter. TD Private Client Wealth LLC now owns 1,732 shares of the medical instruments supplier’s stock worth $171,000 after acquiring an additional 211 shares in the last quarter. Finally, Ballentine Partners LLC acquired a new stake in Merit Medical Systems in the 4th quarter valued at about $200,000. Institutional investors own 99.66% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on MMSI shares. Canaccord Genuity Group lifted their target price on Merit Medical Systems from $127.00 to $128.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Barrington Research lifted their price objective on shares of Merit Medical Systems from $114.00 to $115.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 29th. Needham & Company LLC raised their target price on shares of Merit Medical Systems from $109.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Piper Sandler reissued an “overweight” rating and issued a $116.00 price target (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Finally, Raymond James upped their target price on Merit Medical Systems from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Tuesday, December 31st. Two analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $109.80.

Merit Medical Systems Price Performance

Shares of NASDAQ MMSI opened at $107.76 on Thursday. The business has a fifty day moving average price of $102.16 and a two-hundred day moving average price of $98.57. The stock has a market capitalization of $6.28 billion, a PE ratio of 52.82, a P/E/G ratio of 2.42 and a beta of 0.87. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. Merit Medical Systems, Inc. has a fifty-two week low of $70.70 and a fifty-two week high of $111.45.

Insider Buying and Selling

In other news, Director F. Ann Millner sold 12,500 shares of the business’s stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $101.55, for a total value of $1,269,375.00. Following the completion of the transaction, the director now directly owns 32,391 shares in the company, valued at approximately $3,289,306.05. The trade was a 27.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.70% of the stock is currently owned by company insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.